Heather A. Berger - Jun 13, 2024 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Stock symbol
DSGN
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/17/2024, 05:00 PM
Previous filing
Mar 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DSGN Stock Option (right to buy) Award $0 +19K $0.00 19K Jun 13, 2024 Common Stock 19K $3.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders.